Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome
Neonatology 2012;101(4):306-310
Smits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van Zwet EW, Walther FJ, Lopriore E
co-author, author 3 of 7·doi·pubmed
Summary
An observational study of 313 newborns with alloimmune haemolytic disease, on the incidence, risk factors and outcome of cholestasis. Intrauterine transfusion and rhesus D alloimmunisation were each independently associated with it.
Summary based on the published abstract.
- Type
- Observational study
- Role
- Co-author, author 3 of 7
- Subjects
- haemolytic disease of the fetus and newborn
- PMID
- 22354012
citeSmits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van Zwet EW, Walther FJ, Lopriore E. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology. 2012;101(4):306-310. doi:10.1159/000335333